Precision medicine for gestational diabetes management

FHS
October 9, 2023
10:30 am

Precision markers to predict effective lifestyle and pharmacological interventions to manage Gestational Diabetes Mellitus.

Awakn Life Sciences Submits CTA For Phase III Alcohol Use Disorder Clinical Trial

Awakn Life Sciences Corp. (NEO: AWKN) (OTCMKTS: AWKNF), a biotech firm focused on developing therapies for addiction, with a primary emphasis on Alcohol Use Disorder (AUD), has

September 6, 2023

International society criticizes Utah law for permitting unapproved stem cell therapies

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 19, 2024

Bird flu keeps rewriting the textbooks. It’s why scientists are unsettled by the U.S. dairy cattle outbreak

Twenty-seven years ago today, a 3-year-old boy in Hong Kong developed a sore throat, spiked a fever, and started to cough. Six days later, he

May 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.